Lupeol Suppresses Migration and Invasion Via P38/mapk and PI3K/Akt Signaling Pathways in Human Osteosarcoma U-2 OS Cells

Ming-Jie Hsu,Shu-Fen Peng,Fu-Shin Chueh,Chang-Hai Tsai,Fuu-Jen Tsai,Chih-Yang Huang,Chih-Hsin Tang,Jai-Sing Yang,Yuan-Man Hsu,Wen-Wen Huang,Jing-Gung Chung
DOI: https://doi.org/10.1080/09168451.2019.1606693
2019-01-01
Bioscience Biotechnology and Biochemistry
Abstract:ABSTRACT Lupeol, one of the common components from the fruits and natural foods, has been reported to exert antitumor activities in many human cancer cell lines; however, its effects on osteosarcoma cell metastasis were not elucidated. In the present study, lupeol at 10–25 μM induced cell morphological changes and decreased total viable cell number in U-2 OS cells. Lupeol (5–15 μM) suppressed cell mobility, migration, and invasion by wound healing and transwell chamber assays, respectively. Lupeol inhibited the activities of MMP-2 and −9 in U-2 OS cells by gelatin zymography assay. Lupeol significantly decreased PI3K, pAKT, β-catenin, and increased GSK3β. Furthermore, lupeol decreased the expressions of Ras, p-Raf-1, p-p38, and β-catenin. Lupeol also decreased uPA, MMP-2, MMP-9, and N-cadherin but increased VE-cadherin in U-2 OS cells. Based on these observations, we suggest that lupeol can be used in anti-metastasis of human osteosarcoma cells in the future.
What problem does this paper attempt to address?